Mary: Stage I Invasive Breast Cancer

Mary: Stage I Invasive Breast Cancer

My name is Mary Vetting, and I am an eight-year breast cancer survivor.

Most people think of breast cancer as an older woman’s disease. It turns out, however, that breast cancer is actually the most common cancer in women aged 15-39.

A cancer diagnosis is terrifying for anyone, but it was especially frightening for me as my Mother died of metastatic breast cancer in 1998, after a brave, 14-year battle, at age 55.

As much as I still miss her everyday, the silver lining is that she became my guardian angel in many ways, but specifically in that high-risk specialists began screening me for breast cancer through bi-yearly mammograms, sonograms, and MRIs at age 31 because my Mother was first diagnosed at age 41.

Therefore, my breast cancer was caught early, before it spread.

Terlisa: Survivor Grateful for Second, Third and Fourth Chance at Life!

Terlisa: Survivor Grateful for Second, Third and Fourth Chance at Life!

My name is Terlisa Sheppard, and in November 1998, at the age of 31, while I was 34 weeks pregnant with my second child, I was diagnosed with Stage III breast cancer.

I had been complaining to my gynecologist about feeling a lump under my arm but he informed me that it was probably a milk duct that had formed due to the pregnancy and told me not to worry about it.

Introducing new program formats!

If you receive our program calendar or email newsletter, you may have noticed some new types of educational programs. In addition to our webinars and in-person programs, we are now offering interactive educational opportunities through other platforms. These new kinds of programs offer the same quality content, and make it easy for you to engage with the presenters.

SHARE Expands Chinese Outreach

SHARE has long been a leader in outreach to medically underserved communities. This year, SHARE connected with the Charles B. Wang Community Health Center to seek ways to better support the Chinese community in New York City with its free breast and ovarian cancer services.

Treating Endocrine-Resistant Metastatic Breast Cancer

In September, the FDA approved amebaciclib (Verzenio), the latest drug to treat endocrine resistant metastatic breast cancer (MBC). In combination with fulvestrant (Faslodex), the results of the phase III, Monarch 2 trial showed an improvement in progression free survival (PFS). All the patients in the trial were hormone receptor positive and HER2 negative, as are all the enrollees in the trials noted here.

Update on TAPUR Study

At its annual meeting this year in June, the American Society of Clinical Oncology (ASCO) gave patient advocates an update on the TAPUR clinical trial, which is its first trial. The trial was rolled out about two years ago.

The TAPUR trial (Targeted Agent and Profiling Utilization Registry) allows us to obtain FDA-approved drugs free-of-charge by cutting out the red tape when we are no longer benefiting from any standard treatment.

SHARE Women Featured in Story About BRCA Mutations

Manhattan newspaper Chelsea Now recently ran a story about women who discovered they had a BRCA mutation and how they chose to take preventative action-- or what they decided to do instead. Featured in the story are SHARE's own Breast Cancer Program Director Christine Benjamin, who was diagnosed with early stage breast cancer at age 36 and later found she had an abnormal BRCA1 gene, Ovarian Helpline Coordinator Andrea Herzberg, who had been treated for late stage ovarian cancer before finding she has the BRCA2 mutation, and Deborah Polinsky, a SHARE ovarian cancer support group facilitator and patient advocate living with the BRCA1 mutation.

Potential Benefits for NYC Women with Breast or Ovarian Cancer

SHARE would like to let its constituents know about a program that offers benefits to women in New York City who may have been diagnosed with breast or ovarian cancer as a result of 9/11.

The James Zadroga 9/11 Health and Compensation Act of 2010 established a World Trade Center Health Program to provide high-quality, compassionate healthcare for survivors of 9/11 who lived, worked, or were attending school in the area.

Rosemary: Trusting Her Intuition

Rosemary: Trusting Her Intuition

My hope in sharing my story is to encourage women to trust their intuition and act on it when something doesn’t seem right with their body--even when symptoms might be brushed off by the medical experts, like physicians assistants & even some physicians.

National Helpline:
844-ASK-SHARE